Bavarian Nordic in talks to expand monkeypox vaccine output
LONDON: Bavarian Nordic, the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its CEO said on Monday. The Copenhagen-based vaccine maker!-->!-->…